Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00341549 · ClinicalTrials.gov registry record

Family Myopia Study

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
7,477
Enrollment target

NCT00341549 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 7,477 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00341549 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
7,477 participants
Enrollment target

Study Summary

This study will try to identify the gene or genes responsible for myopia (nearsightedness) and to examine the relationship between myopia and near work. Myopia is the most common eye disorder in the world, affecting one in four Americans. Several studies indicate that myopia is inherited. The condition tends to cluster in families, so that studying families with this condition may facilitate finding the exact cause. Caucasian Americans and African Americans with myopia who are in general good health may be eligible for this study. People with a family history of myopia through several generations along one parent s side only, and in which more than one sibling has myopia are preferred. People who have severe diseases that involve myopia, such as Stickler s or Marfan syndromes, retinitis pigmentosa or diabetic retinopathy may not participate. Participants will undergo the following tests and procedures: * Eye examination, including refraction * Blood draw for genetic studies and possibly establishment of cell lines (collection of cells grown in the laboratory from an original tissue specimen) for future research * Myopia Family Study Questionnaire and personal medical information questionnaire to provide information about other medical conditions that may influence the development of myopia; the vision status of their spouse and children, parents and siblings, and spouse s parents and siblings * Risk Factor Questionnaire (for Jewish Orthodox community only) to assess the amount of near work activity done in childhood

Trial Details

FieldValue
Enrollment Target 7,477 participants
Start Date 2002-04-29
Est. Completion 2020-03-12

What the Registry Record Tells You About NCT00341549

The ClinicalTrials.gov registry entry for NCT00341549 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7,477 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00341549 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00341549 about?

NCT00341549 is a clinical study titled "Family Myopia Study". This study will try to identify the gene or genes responsible for myopia (nearsightedness) and to examine the relationship between myopia and near work. Myopia is the most common eye disorder in the world, affecting one in four Americans. Several studies indicate that myopia is inherited. The condit...

What is the current status of trial NCT00341549?

This trial is currently completed. The enrollment target is 7,477 participants. The study started on 2002-04-29. Estimated completion is 2020-03-12.

Who is sponsoring clinical trial NCT00341549?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.